An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck

Pinette, A; McMichael, E; Courtney, NB; Duggan, M; Benner, BN; Choueiry, F; Yu, LB; Abood, D; Mace, TA; Carson, WE

Mace, TA (reprint author), Ohio State Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, 420 W 12th Ave, Columbus, OH 43210 USA.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019; 68 (8): 1379

Abstract

Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide and epidermal growth factor receptor (EGFR) is overexpr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索